PL2890687T3 - Sole związku benzotiazolowego o aktywności agonisty beta-2-adrenoreceptora - Google Patents

Sole związku benzotiazolowego o aktywności agonisty beta-2-adrenoreceptora

Info

Publication number
PL2890687T3
PL2890687T3 PL13812075T PL13812075T PL2890687T3 PL 2890687 T3 PL2890687 T3 PL 2890687T3 PL 13812075 T PL13812075 T PL 13812075T PL 13812075 T PL13812075 T PL 13812075T PL 2890687 T3 PL2890687 T3 PL 2890687T3
Authority
PL
Poland
Prior art keywords
beta
salts
adrenoceptor agonist
benzothiazolone compound
benzothiazolone
Prior art date
Application number
PL13812075T
Other languages
English (en)
Inventor
Arnaud Grandeury
Nicola Tufilli
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53386469&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2890687(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL2890687T3 publication Critical patent/PL2890687T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13812075T 2012-08-30 2013-08-29 Sole związku benzotiazolowego o aktywności agonisty beta-2-adrenoreceptora PL2890687T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IQ23912 2012-08-30
EP13812075.3A EP2890687B1 (en) 2012-08-30 2013-08-29 Salts of benzothiazolone compound as beta-2-adrenoceptor agonist

Publications (1)

Publication Number Publication Date
PL2890687T3 true PL2890687T3 (pl) 2017-11-30

Family

ID=53386469

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13812075T PL2890687T3 (pl) 2012-08-30 2013-08-29 Sole związku benzotiazolowego o aktywności agonisty beta-2-adrenoreceptora

Country Status (26)

Country Link
EP (2) EP3243817A1 (pl)
KR (1) KR20150047586A (pl)
CN (2) CN104736525B (pl)
BR (1) BR112015004127A2 (pl)
CA (1) CA2882877A1 (pl)
CL (1) CL2015000461A1 (pl)
CY (1) CY1120225T1 (pl)
DK (1) DK2890687T3 (pl)
EA (1) EA029946B1 (pl)
ES (1) ES2642003T3 (pl)
HR (1) HRP20171362T1 (pl)
HU (1) HUE033655T2 (pl)
IL (1) IL237382A0 (pl)
LT (1) LT2890687T (pl)
MA (1) MA37872A1 (pl)
MX (1) MX351741B (pl)
MY (1) MY169038A (pl)
NZ (1) NZ705319A (pl)
PE (1) PE20150465A1 (pl)
PL (1) PL2890687T3 (pl)
PT (1) PT2890687T (pl)
SA (1) SA515360076B1 (pl)
SG (2) SG11201501293PA (pl)
SI (1) SI2890687T1 (pl)
TN (1) TN2015000058A1 (pl)
WO (1) WO2014033654A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078163A2 (en) 2003-02-28 2004-09-16 Transform Pharmaceuticals, Inc. Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AR040962A1 (es) 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
WO2005110990A1 (de) 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Hydroxy-substituierte benzkondensierte heterozyklen als betaagonisten zur behandlung von atemwegserkrankungen
GB0426164D0 (en) * 2004-11-29 2004-12-29 Novartis Ag Organic compounds
JO3192B1 (ar) * 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون
WO2014132205A1 (en) * 2013-02-28 2014-09-04 Novartis Ag Formulation comprising benzothiazolone compound

Also Published As

Publication number Publication date
IL237382A0 (en) 2015-04-30
MA37872A1 (fr) 2018-07-31
EA201590452A1 (ru) 2015-07-30
EP3243817A1 (en) 2017-11-15
TN2015000058A1 (en) 2016-06-29
NZ705319A (en) 2018-05-25
EA029946B1 (ru) 2018-06-29
LT2890687T (lt) 2017-09-11
PE20150465A1 (es) 2015-04-22
HRP20171362T1 (hr) 2017-11-03
CN104736525A (zh) 2015-06-24
CN104736525B (zh) 2016-08-24
HK1206015A1 (en) 2015-12-31
WO2014033654A1 (en) 2014-03-06
DK2890687T3 (en) 2017-10-09
MY169038A (en) 2019-02-07
ES2642003T3 (es) 2017-11-14
SA515360076B1 (ar) 2016-03-20
CL2015000461A1 (es) 2015-05-04
EP2890687B1 (en) 2017-06-28
PT2890687T (pt) 2017-10-05
BR112015004127A2 (pt) 2017-07-04
CA2882877A1 (en) 2014-03-06
SI2890687T1 (sl) 2017-10-30
MX2015002656A (es) 2015-05-20
KR20150047586A (ko) 2015-05-04
SG11201501293PA (en) 2015-03-30
MX351741B (es) 2017-10-26
CN106146428A (zh) 2016-11-23
EP2890687A1 (en) 2015-07-08
SG10201704377PA (en) 2017-06-29
CY1120225T1 (el) 2018-12-12
HUE033655T2 (en) 2017-12-28

Similar Documents

Publication Publication Date Title
IL286152A (en) Modified imidazopyridinyl-aminopyridine compounds
IL232599A (en) Hydrobromide salt of peridofidine
IL236087A0 (en) n–aryltriazole compounds as lpar antagonists
IL236088A0 (en) n-Alkyltriazole compounds as lpar antagonists
GB201106817D0 (en) New compound
ZA201504980B (en) Heterocyclic compound
EP2832734A4 (en) HETEROCYCLIC COMPOUND
EP2709609A4 (en) HETEROCYCLIC COMPOUNDS
GB201120644D0 (en) Herbicidal uses of compounds
LT2822947T (lt) Tlr7 agonisto arginino druskos
ZA201500790B (en) Benzothiazolone compound
EP2940005A4 (en) nitrile
EP2680843A4 (en) DERIVATIVES OF PYRAZOLSUBSTITUTED AMINO-HETEROARYL COMPOUNDS
IL240495A0 (en) A preparation containing a benzothiazolone compound
IL237382A0 (en) Salts of a benzothiazolone compound as beta-2 adrenergic receptor agonists
GB201108347D0 (en) Polymprphic form of compound
GB201108346D0 (en) Polymorphic form of compound
GB201204590D0 (en) Prodrugs of thiazolamine compounds
GB201218018D0 (en) Compounds